These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14050947)

  • 1. [VON WILLEBRAND'S DISEASE. II. EFFECT OF TRANSFUSION OF PLASMA AND PLASMA PRODUCTS].
    VAN CREVELD ; MOCHTAR IA; KOPPE JG; LOPESCARDOZO EB
    Ned Tijdschr Geneeskd; 1963 Sep; 107():1696-700. PubMed ID: 14050947
    [No Abstract]   [Full Text] [Related]  

  • 2. VON WILLEBRAND'S DISEASE. II. EFFECT OF TRANSFUSION OF PLASMA AND OF PLASMA PRODUCTS.
    VAN CREVELD ; MOCHTAR IA; KOPPE JG; CARDOZO EB
    Ann Paediatr; 1963; 201():277-86. PubMed ID: 14111527
    [No Abstract]   [Full Text] [Related]  

  • 3. Transfusion studies in von Willebrand's disease: effect on bleeding time and factor VIII.
    CORNU P; LARRIEU MJ; CAEN J; BERNARD J
    Br J Haematol; 1963 Apr; 9():189-202. PubMed ID: 14023112
    [No Abstract]   [Full Text] [Related]  

  • 4. NORMAL AND POST-EXERCISE PLASMA TRANSFUSION IN PATIENTS WITH HAEMOPHILIA A AND VON WILLEBRAND'S DISEASE.
    IKKALA E; MYLLYLAE G; NEVANLINNA HR
    Scand J Haematol; 1964; 1():300-7. PubMed ID: 14232714
    [No Abstract]   [Full Text] [Related]  

  • 5. SYNTHESIS OF AHF IN VON WILLEBRAND'S DISEASE.
    LEWIS JH
    Blood; 1964 Feb; 23():233-8. PubMed ID: 14122247
    [No Abstract]   [Full Text] [Related]  

  • 6. HETEROZYGOSITY AND HOMOZYGOSITY IN VON WILLEBRAND'S DISEASE.
    BARROW EM; HEINDEL CC; ROBERTS HR; GRAHAM JB
    Proc Soc Exp Biol Med; 1965 Mar; 118():684-7. PubMed ID: 14264528
    [No Abstract]   [Full Text] [Related]  

  • 7. VON WILLEBRAND'S DISEASE: USE OF A PLATELET-ADHESIVENESS TEST IN DIAGNOSIS AND FAMILY INVESTIGATION.
    STRAUSS HS; BLOOM GE
    N Engl J Med; 1965 Jul; 273():171-81. PubMed ID: 14306332
    [No Abstract]   [Full Text] [Related]  

  • 8. STUDIES OF THE ANTIHEMOPHILIC FACTOR (AHF, FACTOR VIII) PRODUCED IN VON WILLEBRAND'S DISEASE.
    BARROW EM; ROBERTS HR; PONS K; GRAHAM JB
    Proc Soc Exp Biol Med; 1964 Mar; 115():760-3. PubMed ID: 14155821
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic studies in von Willebrand's disease: alteration of factor VIII/von Willebrand protein after transfusion with plasma concentrates in patients with von Willebrand's disease.
    Sultan Y; Simeon J; Maisonneuve P; Caen JP
    Thromb Haemost; 1976 Feb; 35(1):110-9. PubMed ID: 1085498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ; Sussman II; Hoyer LW
    J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Question of thrombocytopathy in von Willebrand's disease].
    Barbui T; Battista R; Cazzavillan M; Dini E
    Minerva Med; 1974 Mar; 65(20):1066-70. PubMed ID: 4545297
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-type von Willebrand's disease.
    Miller JL
    Clin Lab Med; 1984 Jun; 4(2):319-31. PubMed ID: 6437734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANTIHEMOPHILIC FACTOR LEVELS IN BLEEDER SWINE FOLLOWING INFUSIONS OF PLASMA AND SERUM.
    MUHRER ME; LECHLER E; CORNELL CN; KIRKLAND JL
    Am J Physiol; 1965 Mar; 208():508-10. PubMed ID: 14264742
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of transfusions of serum during Willebrand's disease].
    Goudemand M; Habay D; Parquet-Gernez A
    Nouv Rev Fr Hematol; 1965; 5(3):492-8. PubMed ID: 4220817
    [No Abstract]   [Full Text] [Related]  

  • 16. Correction of the platelet abnormality in von Willebrand's disease by cryoprecipitate.
    Weiss HJ; Rogers J
    Am J Med; 1972 Dec; 53(6):734-8. PubMed ID: 4539018
    [No Abstract]   [Full Text] [Related]  

  • 17. The spectrum of von Willebrand's disease.
    Bowie EJ; Didisheim P; Thompson JH; Owen CA
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):40-56. PubMed ID: 5299656
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.
    d'Alessio P; Zwaginga JJ; de Boer HC; Federici AB; Rodeghiero F; Castaman G; Mariani G; Mannucci PM; de Groot PG; Sixma JJ
    Thromb Haemost; 1990 Oct; 64(2):227-31. PubMed ID: 2125373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.